# Trial in Periodontal Tissue Regeneration Using Fibroblast Growth Factor-2

> **NCT00514657** · PHASE2 · COMPLETED · sponsor: **Kaken Pharmaceutical** · enrollment: 91 (actual)

## Conditions studied

- Periodontitis

## Interventions

- **DRUG:** Trafermin (genetical recombinant of human basic Fibroblast Growth Factor)

## Key facts

- **NCT ID:** NCT00514657
- **Lead sponsor:** Kaken Pharmaceutical
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-12
- **Primary completion:** —
- **Final completion:** 2004-02
- **Target enrollment:** 91 (ACTUAL)
- **Last updated:** 2007-08-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00514657

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00514657, "Trial in Periodontal Tissue Regeneration Using Fibroblast Growth Factor-2". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00514657. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*